Bevacizumab/erlotinibRash and intratumoural haemorrhage: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2013年 / 1451卷 / 1期

关键词：

D O I：

10.1007/s40278-013-2913-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：11 / 11

相关论文

共 50 条

[1] ErlotinibRash, paronychia and dizziness: 4 case reports
[J]. Reactions Weekly, 2013, 1453 (1) : 21 - 21
[2] Afatinib/erlotinibRash and diarrhoea: 4 case reports
[J]. Reactions Weekly, 2017, 1662 (1) : 24 - 24
[3] Cisplatin/irinotecanCholinergic syndrome and intratumoural haemorrhage: 2 case reports
[J]. Reactions Weekly, 2018, 1698 (1) : 109 - 109
[4] ErlotinibRash: 2 case reports
[J]. Reactions Weekly, 2013, 1444 (1) : 19 - 19
[5] Bevacizumab/temozolomideIneffectiveness and fatal intratumoural haemorrhage with intra-ventricular bleeding: case report
[J]. Reactions Weekly, 2022, 1893 (1) : 76 - 76
[6] Bevacizumab/dalteparin sodiumIntracranial haemorrhage: 7 case reports
[J]. Reactions Weekly, 2012, 1391 (1) : 13 - 13
[7] Bevacizumab/ranibizumabConjunctiva haemorrhage and lens injury: 3 case reports
[J]. Reactions Weekly, 2023, 1958 (1) : 101 - 101
[8] ErlotinibRash, diarrhoea and paronychia: 2 case reports
[J]. Reactions Weekly, 2012, 1389 (1) : 22 - 22
[9] ErlotinibRash and gastrointestinal toxicities: 24 case reports
[J]. Reactions Weekly, 2020, 1832 (1) : 139 - 139
[10] AnastrozoleRetinal haemorrhage: 4 case reports
[J]. Reactions Weekly, 2008, 1205 (1) : 6 - 6

← 1 2 3 4 5 →